CN1324147C - 细小病毒b19的诊断测试 - Google Patents

细小病毒b19的诊断测试 Download PDF

Info

Publication number
CN1324147C
CN1324147C CNB028128168A CN02812816A CN1324147C CN 1324147 C CN1324147 C CN 1324147C CN B028128168 A CNB028128168 A CN B028128168A CN 02812816 A CN02812816 A CN 02812816A CN 1324147 C CN1324147 C CN 1324147C
Authority
CN
China
Prior art keywords
sequence
seq
gly
leu
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028128168A
Other languages
English (en)
Chinese (zh)
Other versions
CN1636071A (zh
Inventor
S·皮谢安特斯
V·夏玛拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grifols Worldwide Operations Ltd
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of CN1636071A publication Critical patent/CN1636071A/zh
Application granted granted Critical
Publication of CN1324147C publication Critical patent/CN1324147C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CNB028128168A 2001-06-28 2002-06-28 细小病毒b19的诊断测试 Expired - Fee Related CN1324147C (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US30207701P 2001-06-28 2001-06-28
US60/302,077 2001-06-28
US36595602P 2002-03-19 2002-03-19
US60/365,956 2002-03-19
US36922402P 2002-03-29 2002-03-29
US60/369,224 2002-03-29
PCT/US2002/020684 WO2003002753A2 (en) 2001-06-28 2002-06-28 Diagnostic assays for parvovirus b19

Publications (2)

Publication Number Publication Date
CN1636071A CN1636071A (zh) 2005-07-06
CN1324147C true CN1324147C (zh) 2007-07-04

Family

ID=28794978

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028128168A Expired - Fee Related CN1324147C (zh) 2001-06-28 2002-06-28 细小病毒b19的诊断测试

Country Status (20)

Country Link
US (2) US6936442B2 (enExample)
EP (1) EP1537235B1 (enExample)
JP (5) JP2005511004A (enExample)
KR (2) KR100944674B1 (enExample)
CN (1) CN1324147C (enExample)
AU (2) AU2002318450B2 (enExample)
BG (1) BG66283B1 (enExample)
BR (1) BRPI0211191B8 (enExample)
CA (2) CA2779653C (enExample)
CZ (1) CZ308201B6 (enExample)
ES (1) ES2537549T3 (enExample)
HK (1) HK1080516B (enExample)
HU (1) HU230244B1 (enExample)
MX (1) MXPA03011802A (enExample)
NO (1) NO337901B1 (enExample)
NZ (1) NZ530602A (enExample)
PL (1) PL210849B1 (enExample)
RU (1) RU2301263C2 (enExample)
SK (1) SK15752003A3 (enExample)
WO (1) WO2003002753A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002323520B2 (en) * 2001-08-31 2008-02-21 Gen-Probe Incorporated Assay for detection of human parvovirus B19 nucleic acid
US8242254B2 (en) 2003-09-11 2012-08-14 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
WO2005071401A2 (en) * 2004-01-15 2005-08-04 Chiron Corporation Homogeneous multiplex assay for nucleic acid targets
US20060057643A1 (en) * 2004-09-10 2006-03-16 Mccarthy Laurence R Methods and compositions for detecting erythrovirus genotypes
WO2006137939A2 (en) * 2004-11-09 2006-12-28 Gen-Probe Incorporated Compositions and methods for detecting group a streptococci
US8058000B2 (en) * 2005-06-02 2011-11-15 The United States Of America As Represented By The U.S. Environmental Protection Agency Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment
US7572584B2 (en) * 2005-06-02 2009-08-11 The United States Of America As Represented By The U.S. Environmental Protection Agency Species-specific primer sets and identification of species-specific DNA sequences using genome fragment enrichment
DE102006034844B3 (de) * 2006-07-27 2007-12-06 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Zusammensetzungen und Verfahren zur Amplifikation von Hepatitis A-Viren (HAV) und/oder Parvoviren B19 (PB19) mittels Multiplex-PCR
AU2008206309A1 (en) 2007-01-16 2008-07-24 Talecris Biotherapeutics, Inc. Human erythrovirus
WO2009038840A2 (en) * 2007-06-14 2009-03-26 Ibis Biosciences, Inc. Compositions for use in identification of adventitious contaminant viruses
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
NZ599585A (en) * 2007-06-14 2013-12-20 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
EP2300819A4 (en) * 2008-07-23 2011-11-23 Nat Univ Gyeongsang Iacf METHOD AND SYSTEM FOR VIRUS DIAGNOSIS
AU2010217928B2 (en) 2009-02-26 2013-06-06 Gen-Probe Incorporated Assay for detection of human parvovirus nucleic acid
US9598739B1 (en) 2009-03-13 2017-03-21 Grifols Therapeutics Inc. Human erythrovirus
BR112012025364A2 (pt) 2010-04-07 2015-09-22 Novartis Ag método para geração de partícula semelhante a vírus de parvovírus b19
JP6150795B2 (ja) 2011-07-15 2017-06-28 ジェン−プロウブ インコーポレイテッド シングルプレックス又はマルチプレックスアッセイにおいてヒトパルボウイルス核酸を検出及びa型肝炎ウイルス核酸を検出するための組成物及び方法
CN103451320B (zh) * 2013-08-09 2015-05-06 中国人民解放军军事医学科学院野战输血研究所 人细小病毒B19三种基因型的实时荧光定量PCR检测方法及其通用检测引物、TaqMan探针与试剂盒
US9410172B2 (en) * 2013-09-16 2016-08-09 General Electric Company Isothermal amplification using oligocation-conjugated primer sequences
CN110845581A (zh) 2014-03-10 2020-02-28 路易斯维尔大学研究基金会有限公司 用于治疗(包括预防)细小病毒感染及相关疾病的组合物和方法
CN103820581B (zh) * 2014-03-17 2016-01-13 成都蓉生药业有限责任公司 一种检测人细小病毒b19的试剂盒和方法
JP6414409B2 (ja) * 2014-07-29 2018-10-31 株式会社微生物化学研究所 弱毒化パルボウイルスおよび弱毒化パルボウイルスを用いたワクチン
BR112017009321B1 (pt) * 2014-11-05 2024-03-05 King George's Medical University Sonda, mistura reacional, e, kit de teste
TWI804917B (zh) * 2015-03-27 2023-06-11 美商再生元醫藥公司 偵測生物污染物之組成物及方法
CN105158471A (zh) * 2015-08-24 2015-12-16 北京中检安泰诊断科技有限公司 人细小病毒B19型IgM抗体检测试剂盒及其制备方法
CN114410836B (zh) * 2021-12-17 2024-03-01 上海交通大学医学院附属仁济医院 一种集样本处理、核酸提取及多重恒温扩增一体化的检测人细小病毒b19的试剂盒和方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399491A (en) * 1989-07-11 1995-03-21 Gen-Probe Incorporated Nucleic acid sequence amplification methods

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516630A (en) 1983-09-30 1996-05-14 The United States Of America As Represented By The Department Of Health And Human Services Methods of detecting hepatitis A virus
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
NL8902301A (nl) 1989-09-14 1991-04-02 Rijksuniversiteit Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins.
US6379885B1 (en) * 1989-09-14 2002-04-30 Rijksuniversiteit Te Leiden Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
US6204044B1 (en) * 1989-09-14 2001-03-20 Caroline Sarah Brown Human parvovirus B19 proteins and virus-like particles, their production and their use in diagnostic assays and vaccines
DE4003826C2 (de) 1990-02-08 1995-11-23 Mikrogen Molekularbiol Entw Peptide der Kapsidproteine VP1 oder VP2 des Parvovirus B19
WO1994010294A1 (en) 1992-10-23 1994-05-11 New York University Human monoclonal antibodies to human parvovirus and methods of making and using thereof
US5449608A (en) 1993-03-22 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Parvovirus B19 receptor and parvovirus B19 detection
JPH06293798A (ja) 1993-04-06 1994-10-21 Shin Etsu Chem Co Ltd ヒトパルボウイルスb19のエピトープ関連ペプチド
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
EP0783580A2 (en) 1994-09-22 1997-07-16 Wolf, Hans Joachim Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19
US6004044A (en) * 1995-05-03 1999-12-21 Itt Cannon, Inc. Optoelectric connector
JPH0910000A (ja) 1995-06-26 1997-01-14 Nippon Sekijiyuujishiya ヒトパルボウイルスの検出方法及びそのための試薬
BR9611309A (pt) * 1995-11-13 1999-03-02 Shionogi & Co Diagnóstico de doenças associadas ao espasmo da artéria coronária
AU6267596A (en) 1995-12-14 1997-07-03 Steritech, Inc. Inactivation of non-enveloped virus
US6094338A (en) * 1997-07-09 2000-07-25 Mitsubishi Chemical Corporation Electric double-layer capacitor
AU1269699A (en) 1997-10-08 1999-04-27 Advanced Research And Technology Institute, Inc. Chimeric parvovirus-based recombinant vector system that specifically targets the erythroid lineage
DE19752898A1 (de) 1997-11-28 1999-08-05 Centeon Pharma Gmbh Verfahren zum Nachweis hoher Vierenkonzentrationen im Blutplasma und/oder Blutserum mittels der Polymerasekettenreaktion
CA2318880C (en) * 1998-02-04 2010-07-27 Perkin-Elmer Corporation Determination of a genotype of an amplification product at multiple allelic sites
RU2146372C1 (ru) * 1998-04-16 2000-03-10 Гематологический научный центр РАМН Способ определения парвовируса б19
US6238860B1 (en) * 1998-11-05 2001-05-29 Dyax Corp. Binding moieties for human parvovirus B19
US6642033B1 (en) 1999-07-20 2003-11-04 V.I. Technologies, Inc. Nucleic acids for detecting parvovirus and methods of using same
JP4796252B2 (ja) * 1999-07-23 2011-10-19 ジェン−プローブ・インコーポレーテッド ポリヌクレオチド増幅方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399491A (en) * 1989-07-11 1995-03-21 Gen-Probe Incorporated Nucleic acid sequence amplification methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Multiple primer pairs for polymerase chain reactionamplification of human parvovirus B19 DNA. J. Virol. Meth.,Vol.44 1993 *
Nucleic acid sequence detection systems:revolutionaryautomation for monitoring and reporting PCR products Australasian Biotechnology,Vol.6 No.5 1996 *

Also Published As

Publication number Publication date
US20030170612A1 (en) 2003-09-11
CA2779653A1 (en) 2003-01-09
AU2002318450B2 (en) 2007-11-22
JP2009011324A (ja) 2009-01-22
BG108526A (bg) 2004-09-30
JP2014061007A (ja) 2014-04-10
PL368049A1 (en) 2005-03-21
NO337901B1 (no) 2016-07-04
EP1537235B1 (en) 2015-04-01
NZ530602A (en) 2006-02-24
ES2537549T3 (es) 2015-06-09
BR0211191A (pt) 2006-05-23
KR20050119220A (ko) 2005-12-21
HK1080516A1 (en) 2006-04-28
NO20035732D0 (no) 2003-12-19
RU2004102205A (ru) 2005-06-10
AU2007231822B2 (en) 2011-01-27
EP1537235A2 (en) 2005-06-08
CA2779653C (en) 2014-08-19
KR100944674B1 (ko) 2010-03-04
CZ308201B6 (cs) 2020-02-26
PL210849B1 (pl) 2012-03-30
BRPI0211191B1 (pt) 2015-09-15
AU2007231822A1 (en) 2007-11-29
KR100888377B1 (ko) 2009-03-13
HU230244B1 (hu) 2015-11-30
EP1537235A4 (en) 2007-10-03
NO20035732L (no) 2004-02-27
WO2003002753A3 (en) 2005-04-14
CA2451756A1 (en) 2003-01-09
BRPI0211191B8 (pt) 2021-07-27
WO2003002753A2 (en) 2003-01-09
HUP0600779A2 (en) 2007-01-29
JP6026401B2 (ja) 2016-11-16
MXPA03011802A (es) 2004-04-02
SK15752003A3 (sk) 2005-01-03
KR20090003370A (ko) 2009-01-09
HUP0600779A3 (en) 2010-03-29
US20050221300A1 (en) 2005-10-06
RU2301263C2 (ru) 2007-06-20
US6936442B2 (en) 2005-08-30
JP2016182149A (ja) 2016-10-20
HK1080516B (zh) 2008-01-25
JP2012075440A (ja) 2012-04-19
CZ20033516A3 (cs) 2005-02-16
CN1636071A (zh) 2005-07-06
BG66283B1 (bg) 2013-01-31
JP2005511004A (ja) 2005-04-28

Similar Documents

Publication Publication Date Title
CN1324147C (zh) 细小病毒b19的诊断测试
CN1286985C (zh) 与疾病相关的核酸
CN1258604C (zh) 一种用于检测非致病性或致病性a型流感病毒h5亚型病毒的试剂盒
CN1798851A (zh) 通过核酸扩增检测1型和2型单纯疱疹病毒
CN1639357A (zh) 检测人乳头瘤病毒mRNA的方法
CN1827780A (zh) 有效检测丙型肝炎病毒(hcv)的寡核苷酸引物及其应用方法
CN1646705A (zh) 检测和分型人乳头瘤病毒的扩增-杂交方法
CN100345980C (zh) 检测乙型肝炎病毒的pcr引物组,使用该引物组检测乙型肝炎的方法以及包含该引物组的乙肝病毒检测试剂盒
CN100340674C (zh) 耳聋相关基因突变及其检测方法
CN1300582C (zh) Eb病毒蛋白酶联免疫吸附诊断试剂盒及其制备方法
CN1193997A (zh) 产生和纯化并测定具有hcvns3蛋白酶蛋白水解活性的多肽的方法
CN1578789A (zh) 新的丙型肝炎病毒基因型及其作为预防剂、治疗剂和诊断剂的用途
CN1646704A (zh) 确定致病性病毒对蛋白酶抑制剂敏感性的组合物和方法
CN1948503A (zh) 一种人乳头瘤病毒检测分型方法及试剂盒
CN1675378A (zh) 用于甲型肝炎病毒核酸捕捉、检测和定量的寡核苷酸的鉴定
CN1798842A (zh) 核酸检测
CN1687454A (zh) 基于环介导的等温扩增技术的血液病毒核酸筛查方法
CN1813064A (zh) 检测sars冠状病毒的方法
CN1690223A (zh) 人乳头瘤病毒分型基因芯片检测系统
CN1566131A (zh) 攻击人类乙型肝炎病毒的小干扰RNA分子(SiRNA)及其应用
CN1860240A (zh) Sars和其它病毒病的酶诊断试验
CN1455814A (zh) 日本人戊型肝炎病毒多核苷酸探针和引物,检测芯片、试剂盒,以及检测方法
CN1276094C (zh) 用于诊断地中海贫血的dna芯片
CN1906306A (zh) Sars相关冠状病毒的多等位分子检测
CN1882690A (zh) 从新hcv株衍生的核酸和基因以及使用所述基因的复制子-复制细胞

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1080516

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: NOVARTIS VACCINES & DIAGNOSTIC

Free format text: FORMER NAME OR ADDRESS: CHIRON CORP.

CP03 Change of name, title or address

Address after: Delaware

Patentee after: Novartis Vaccines & Diagnostic Inc.

Address before: California, USA

Patentee before: Chiron Corporation

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20160912

Address after: Dublin, Ireland

Patentee after: GRIFOLS WORLDWIDE OPERATIONS LIMITED

Address before: Delaware

Patentee before: Novartis Vaccines & Diagnostic Inc.

CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20070704

Termination date: 20210628